Ocimum Biosolutions acquires Isogen arm

HYDERABAD: Ocimum Biosolutions, provider of laboratory information management systems (LIMS), has acquired the BioMolecules synthesis business of Isogen Life Science based in The Netherlands.

Anuradha Acharya, CEO of Ocimum Biosolutions, said, "We are very pleased to have taken a significant step towards becoming a global oligo player with the Isogen acquisition. This acquisition will also help us become a more integrated genomics services provider with three delivery points in Indianapolis, IJsselstein and Hyderabad."

Avendus Advisors was the sole financial advisor to Ocimum for the deal. Shiraz Bugwadia, AVP, Avendus Advisors "Ocimum is one of the few Indian players within the BioIT and microarrays space to have scaled up successfully over the last couple of years. Ocimum has also been successful at using the inorganic route to scale rapidly by acquiring niche good quality companies in Europe such as MWG Biotech's division and now Isogen Life Science."

© CyberMedia News